← Eichor
Study identifier: NCT06676774 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

Condition: Arginine Vasopressin Deficiency · Diabetes Insipidus  ·  Sponsor: University Hospital, Basel, Switzerland

PhasePhase 2
Planned participants42
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This study aims to investigate the potential beneficial effects of intranasal oxytocin compared to placebo on emotion recognition and acute psychosocial stress in patients with arginine vasopressin deficiency compared to matched healthy controls.

This description comes directly from the study's public registry record.

Talk to the study team

Mirjam Christ-Crain, Prof. Dr.  ·  +41 61 328 70 80  ·  mirjam.christ-crain@ubs.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital BaselBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06676774